Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Performance Evaluation of the Lucira COVID-19 & Flu Test

NCT06141824

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Benchmark Research Colton, California, United States
  • Carbon Health Oakland, California, United States
  • Koch Family Medicine Morton, Illinois, United States
View Trial Details
Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

NCT05568979

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number : 2-2-002 Helsinki, Finland
  • Investigational Site Number : 2-2-005 Jyväskylä, Finland
  • Investigational Site Number : 2-2-004 Kuopio, Finland
  • Investigational Site Number : 2-2-006 Rauma, Finland
View all 15 locations
View Trial Details
Completed

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

NCT04669691

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 23302- Al Mare Perearstikeskus OÜ Tallinn, Harju, Estonia
  • 23301- Clinical Research Center Tartu, Estonia
  • 60805 - De La Salle Medical and Health Sciences Institute Dasmariñas, Manila, Philippines
  • 60804 - University of Perpetual Help Dalta Medical Center Las Piñas, Manila, Philippines
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

NCT05052697

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • The Heart Center Athens, Alabama, United States
  • Arizona Heart Rhythm Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
View all 100 locations
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

NCT05585632

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations
  • Accel Research Sites DeLand, Florida, United States
  • Research Centers of America (cenexel) Hollywood, Florida, United States
  • Accel Research Sites St. Petersburg, Florida, United States
  • Atlanta Center for Medical Research - Family Medicine Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

NCT05375838

Conditions
Infections, Influenza, Influenza, Human, +6 more
Locations
  • Research Centers of America Hollywood, Florida, United States
  • AES - DRS - Optimal Research Illinois - Peoria Peoria, Illinois, United States
  • Meridian Sioux City, Iowa, United States
  • Benchmark Research Metairie, Louisiana, United States
View all 14 locations
View Trial Details
Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

NCT05981846

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • CAP Centelles Centelles, Barcelona, Spain
  • Hospital HM Modelo A Coruña, Spain
View Trial Details

Related conditions